Pritelivir (BAY 57-1293) Transwell-COL

Pritelivir (BAY 57-1293) Transwell-COLPritelivir (BAY 57 1293) is a potent helicase primase inhibitor, exhibiting antiviral effect on herpes simplex virus (HSV) with IC50 of 20 nM for both HSV 1 and HSV 2.

Asunaprevir is an orally bioavailable inhibitor of the hepatitis C virus enzyme serine protease NS3 that is necessary for protein processing required for viral replication

and glucose

B pathways

UNC2025 is a potent and orally bioavailable dual MER/FLT3 inhibitor with IC50 of 0

and are the ideal single and multichannel pipetting stations

watermelon

which inhibits bacterial cell-wall synthesis (peptidoglycan cross-linking) by inactivating transpeptidases on the inner surface of the bacterial cell membrane

anti-inflammatory antiarthritic agent

-adrenergic receptor agonist of the amphetamine class used as a bronchodilator

one of the active phytochemicals in licorice extract

ALIBI memory provides data protection and facilitates automatic measurement recording (max 500 000 weighing records)

CAY10505 is dehydroxyl of AS-252424